Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology All Pharmacokinetics-pharmacodynamics (PK-PD) of aztreonam-avibactam (ATM-AVI) in Special PopulationsRelease Date:Research Inflammation & Immunology Austria, Denmark, Finland, Germany, Italy, Netherlands, Norway, Romania, Spain, Sweden, United Kingdom Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with IsavuconazoleRelease Date:Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland Optimizing maternal immunization practice in Malaysia Indonesia Singapore PhilippinesRelease Date:Quality Improvement Vaccines Indonesia, Malaysia, Philippines, Singapore PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate CancerRelease Date:Education Oncology USA Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026Release Date:Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infectionRelease Date:Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac eraRelease Date:Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRERelease Date:Research Hospital China, Hong Kong Title Grant Type Focus Area Country Application Due Date 2024 Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Rare Disease All Junior Investigator Global ATTR Cardiac Amyloidosis ResearchRelease Date:Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain Reducing Barriers to Optimal Clinical Care in Breast CancerRelease Date:Quality Improvement Oncology Spain Quality Improvement Grants to Improve Identification and Management of Patients with ATTR AmyloidosisRelease Date:Quality Improvement Rare Disease Spain Advances in Migraine ManagementRelease Date:Education Internal Medicine USA 2024 IM US Headache Medicine FellowshipRelease Date:Fellowship Internal Medicine USA RSV Infection and RSV Maternal Immunization in Area of Obstetrics and GynecologyRelease Date:Education Vaccines Japan Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous ThromboembolismEducation Internal Medicine All Bolstering Clinical Research Capacity to Address China Health Equity DisparitiesRelease Date:Education Health Equity China Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease USA